Abstract
Microneedles (MNs) coupled with lateral flow assay (LFA) systems represent an emerging diagnostic technology with significant potential due to their low cost, ease of use, and minimally invasive nature. These systems allow the extraction of interstitial fluid (IFS) through micrometric channels, enabling the detection of biomarkers for infectious diseases with reduced pain and fewer side e…